Multi-modal machine learning for predicting amyloid positivity using on-ramp driving.

IF 4.4 Q1 CLINICAL NEUROLOGY
Sai Santosh Reddy Danda, Yi Lu Murphey, Amanda Maher, Carol Persad, Savannah Rose, Robert Koeppe, Bruno Giordani
{"title":"Multi-modal machine learning for predicting amyloid positivity using on-ramp driving.","authors":"Sai Santosh Reddy Danda, Yi Lu Murphey, Amanda Maher, Carol Persad, Savannah Rose, Robert Koeppe, Bruno Giordani","doi":"10.1002/dad2.70161","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Early detection of amyloid p is critical for Alzheimer's disease (AD) risk identification. This study leverages machine learning of multi-modal attributes, including vehicular, physiological, and demographic data, to classify older adults with and without amyloid positivity.</p><p><strong>Methods: </strong>Driving data and physiological responses from 53 cognitively normal older drivers with known positron emission tomography amyloid status were collected during freeway on-ramp, merging, and post-merge stages of a fixed-course drive. Statistically significant features (<i>P ≤</i> 0.05) were used to train random forest and XGBoost classifiers to classify amyloid-positive and -negative participants, with feature importance evaluated based on model performance.</p><p><strong>Results: </strong>Integrating multiple data modalities (demographics, vehicular, and physiological features) improved classification performance, distinguishing amyloid status. XGBoost with all statistically significant features achieved the highest accuracy (85.1%). Vehicular data provided the most predictive power, highlighting driving behavior relevance for classification.</p><p><strong>Discussion: </strong>Results underscore the importance of complementary insights from on-ramp multi-modal data to predict amyloid status and potential early AD detection.</p><p><strong>Highlights: </strong>We analyzed driving behavior and physiological signals for cognitive decline detection.Artificial intelligence (AI) models (random forest, XGBoost) effectively classified amyloid beta positive and negative participants.Interpretable AI identified on-ramp driving, that is, ZOI_1, as key for classification.Multi-modal analysis during on-ramp driving aids early cognitive decline detection.Challenging traffic environments enable non-invasive cognitive health monitoring.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 3","pages":"e70161"},"PeriodicalIF":4.4000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340426/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Early detection of amyloid p is critical for Alzheimer's disease (AD) risk identification. This study leverages machine learning of multi-modal attributes, including vehicular, physiological, and demographic data, to classify older adults with and without amyloid positivity.

Methods: Driving data and physiological responses from 53 cognitively normal older drivers with known positron emission tomography amyloid status were collected during freeway on-ramp, merging, and post-merge stages of a fixed-course drive. Statistically significant features (P ≤ 0.05) were used to train random forest and XGBoost classifiers to classify amyloid-positive and -negative participants, with feature importance evaluated based on model performance.

Results: Integrating multiple data modalities (demographics, vehicular, and physiological features) improved classification performance, distinguishing amyloid status. XGBoost with all statistically significant features achieved the highest accuracy (85.1%). Vehicular data provided the most predictive power, highlighting driving behavior relevance for classification.

Discussion: Results underscore the importance of complementary insights from on-ramp multi-modal data to predict amyloid status and potential early AD detection.

Highlights: We analyzed driving behavior and physiological signals for cognitive decline detection.Artificial intelligence (AI) models (random forest, XGBoost) effectively classified amyloid beta positive and negative participants.Interpretable AI identified on-ramp driving, that is, ZOI_1, as key for classification.Multi-modal analysis during on-ramp driving aids early cognitive decline detection.Challenging traffic environments enable non-invasive cognitive health monitoring.

使用匝道驾驶预测淀粉样蛋白阳性的多模态机器学习。
淀粉样蛋白p的早期检测对阿尔茨海默病(AD)的风险识别至关重要。本研究利用机器学习的多模态属性,包括车辆、生理和人口统计数据,对淀粉样蛋白阳性和非淀粉样蛋白阳性的老年人进行分类。方法:收集53名认知正常、正电子发射断层扫描淀粉样蛋白状态的老年驾驶员在高速公路入匝道、合并和合并后三个阶段的驾驶数据和生理反应。使用统计学显著特征(P≤0.05)训练随机森林和XGBoost分类器对淀粉样蛋白阳性和阴性参与者进行分类,并根据模型性能评估特征重要性。结果:整合多种数据模式(人口统计,车辆和生理特征)提高了分类性能,区分淀粉样蛋白状态。具有所有统计显著特征的XGBoost实现了最高的准确率(85.1%)。车辆数据提供了最大的预测能力,突出了驾驶行为的相关性进行分类。讨论:结果强调了从入站多模态数据中获得的互补见解对预测淀粉样蛋白状态和潜在的早期AD检测的重要性。重点:我们分析了驾驶行为和认知衰退检测的生理信号。人工智能(AI)模型(随机森林,XGBoost)有效地对β淀粉样蛋白阳性和阴性参与者进行了分类。可解释的AI识别入匝道驾驶,即ZOI_1,作为分类的关键。入匝道驾驶过程中的多模态分析有助于早期认知衰退检测。具有挑战性的交通环境使非侵入性认知健康监测成为可能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
7.50%
发文量
101
审稿时长
8 weeks
期刊介绍: Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信